Novartis Announced A Partnership With The American Society Of Haematology (Ash) To Provide Six Additional African Nations With Technology That Is Already Being Used In Ghana To Document And Share The Diagnosis Of Babies With Sickle Cell Disease. Early Diagnosis Is Key To Managing The Disease And Ensuring Better Health Outcomes To Improve The Quality Of Life For People Living With Scd. The Partnership With Ash Will Not Only Deliver Better Tools To Track A Baby
